Nascent Biotech Inc. Annual Income Tax Expense (Benefit) in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Nascent Biotech Inc. annual/quarterly Income Tax Expense (Benefit) history and growth rate from 2016 to 2023.
  • Nascent Biotech Inc. Income Tax Expense (Benefit) for the quarter ending December 31, 2022 was $0.000.
  • Nascent Biotech Inc. annual Income Tax Expense (Benefit) for 2023 was $0.000.
  • Nascent Biotech Inc. annual Income Tax Expense (Benefit) for 2022 was $0.000.
  • Nascent Biotech Inc. annual Income Tax Expense (Benefit) for 2021 was $0.000.
Income Tax Expense (Benefit), Annual (USD)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $0 $0 Apr 1, 2023 Mar 31, 2024 10-K 2024-07-01
2022 $0 $0 Apr 1, 2022 Mar 31, 2023 10-K 2024-07-01
2021 $0 $0 Apr 1, 2021 Mar 31, 2022 10-K/A 2023-07-03
2020 $0 $0 Apr 1, 2020 Mar 31, 2021 10-K 2022-06-15
2019 $0 $0 Apr 1, 2019 Mar 31, 2020 10-K 2020-06-22
2018 $0 Apr 1, 2018 Mar 31, 2019 10-K 2020-06-22
2016 $240K Apr 1, 2016 Mar 31, 2017 10-K 2018-06-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.